Significant Ownership of InnoCare Pharma Inc.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for InnoCare Pharma Inc. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Jisong Cui - By Jisong Cui, Chairperson and CEO
- Manager location
- Princeton, NJ
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow InnoCare Pharma Inc. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from InnoCare Pharma Inc.
Significant Ownership of InnoCare Pharma Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | Common Stock, par value $0.0001 per share | 9.4% | $111,026,500 | 5,000,000 | InnoCare Pharma Inc. | 07 Oct 2025 |
Schedules 13D/G Reported by InnoCare Pharma Inc.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.